Eli Lilly has reported a robust start for its newly launched oral weight-loss medication, Foundayo, with more than 20,000 patients beginning treatment within the first few weeks of its release. CEO Dave Ricks confirmed that the drug is currently seeing an adoption rate of approximately 1,000 new patients per day, signaling significant organic interest in […]